Archive: 26/10/2020
Germany's Bayer to buy US gene therapy specialist AskBio
German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billion.
Oct 26, 2020